Skip to main content

Table 2 Trend in suicide mortality by calendar year of diagnosis, age at diagnosis and latency after PCa diagnosis among PCa patients

From: Trends in suicide mortality among prostate cancer survivors in the United States, 1975–2019

 

SMR

95%CI

Overall

1.15

1.09–1.2*

Calendar year of diagnosis

  

1975–1979

1.74

1.17–2.51*

1980–1984

1.41

1.08–1.8*

1985–1989

2.01

1.72–2.34*

1990–1994

1.56

1.35–1.78*

1995–1999

1.18

1.02–1.35*

2000–2004

1.1

0.96–1.25

2005–2009

0.98

0.86–1.11

2010–2014

0.98

0.88–1.1

2015–2019

0.99

0.89–1.1

Ptrend (Coefficient)

< 0.001 (-0.091)

 
 

SMR

95%CI

Age at diagnosis (year)

  

45–49

0.72

0.2–1.85

50–54

0.94

0.6–1.41

55–59

0.96

0.74–1.23

60–64

0.98

0.81–1.18

65–69

1.16

1.01–1.33*

70–74

1.24

1.11–1.38*

75–79

1.13

1.01–1.25*

80–84

1.16

1.04–1.29*

85+

1.20

1.08–1.33*

Ptrend (Coefficient)

0.078(0.023)

 
 

SMR

95%CI

Latency after PCa diagnosis (month)

  

0–11

1.26

1.09–1.46*

12–59

1.11

1.02–1.2*

60–119

1.17

1.07–1.27*

120+

1.13

1.04–1.24*

Ptrend (Coefficient)

0.599(-0.012)

 
  1. SMR: standardized mortality rate, CI: confidence interval, PCa: prostate cancer,
  2. *: statistical significance